DE2017081A1 - Adenin-Derivate und Verfahren zu ihrer Herstellung - Google Patents

Adenin-Derivate und Verfahren zu ihrer Herstellung

Info

Publication number
DE2017081A1
DE2017081A1 DE19702017081 DE2017081A DE2017081A1 DE 2017081 A1 DE2017081 A1 DE 2017081A1 DE 19702017081 DE19702017081 DE 19702017081 DE 2017081 A DE2017081 A DE 2017081A DE 2017081 A1 DE2017081 A1 DE 2017081A1
Authority
DE
Germany
Prior art keywords
acid
amino
adenyl
pharmaceutically acceptable
dihydroxybutyric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702017081
Other languages
German (de)
English (en)
Inventor
Ichiro Suita; Inoue Iehizo Ikeda; Matsumoto Kazuo Takatsuki; Osaka; Okumura Kentaro Kobe Hyogo; Kodera Keiji Toda Saitama; Takeyama Shigeyuki Saitama; Yamada Yoshihisa Nara; Adachi Takeshi Osaka; Chibata (Japan). P C07d
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of DE2017081A1 publication Critical patent/DE2017081A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Invalid Beds And Related Equipment (AREA)
DE19702017081 1969-04-09 1970-04-09 Adenin-Derivate und Verfahren zu ihrer Herstellung Pending DE2017081A1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2778769 1969-04-09
JP4113069 1969-05-26
JP4113169 1969-05-26
JP4262369 1969-05-30

Publications (1)

Publication Number Publication Date
DE2017081A1 true DE2017081A1 (de) 1970-10-22

Family

ID=27458759

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702017081 Pending DE2017081A1 (de) 1969-04-09 1970-04-09 Adenin-Derivate und Verfahren zu ihrer Herstellung

Country Status (7)

Country Link
BE (1) BE748658A (enrdf_load_stackoverflow)
DE (1) DE2017081A1 (enrdf_load_stackoverflow)
FR (1) FR2042314B1 (enrdf_load_stackoverflow)
GB (1) GB1290594A (enrdf_load_stackoverflow)
IL (1) IL34188A (enrdf_load_stackoverflow)
NL (1) NL7005039A (enrdf_load_stackoverflow)
NO (1) NO124836B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3763406A1 (en) 2019-07-12 2021-01-13 Sanofi Method and electronic device for acquiring delivery information

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3763406A1 (en) 2019-07-12 2021-01-13 Sanofi Method and electronic device for acquiring delivery information

Also Published As

Publication number Publication date
FR2042314A1 (enrdf_load_stackoverflow) 1971-02-12
GB1290594A (enrdf_load_stackoverflow) 1972-09-27
IL34188A0 (en) 1970-05-21
NL7005039A (enrdf_load_stackoverflow) 1970-10-13
IL34188A (en) 1972-12-29
NO124836B (enrdf_load_stackoverflow) 1972-06-12
FR2042314B1 (enrdf_load_stackoverflow) 1974-01-11
BE748658A (en) 1970-09-06

Similar Documents

Publication Publication Date Title
DE2760372C2 (enrdf_load_stackoverflow)
DE2756653C2 (de) 5'-Deoxy-5-fluorcytidin und 5'- Deoxy-5-fluoruridin, deren Isopropylidenderivate und Salze und Verfahren zu deren Herstellung
DE2918261C2 (enrdf_load_stackoverflow)
DE1695151A1 (de) Verfahren zur Herstellung von Nucleosiden
EP0022192B1 (de) 1-Alkadien-2,4-yl-2-hydroxymethyl-3,4,5-trihydroxy-piperidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE1132926B (de) Verfahren zur Herstellung von 2'-Desoxy-5-fluor-cytidin und dessen ª‡-Isomeren
DE1917874B2 (de) 14-Halogendaunomycine, Verfahren zu ihrer Herstellung und deren Verwendung zur Herstellung von Adriamycin
CH646149A5 (de) Pyrrolidin-derivat.
DE2017081A1 (de) Adenin-Derivate und Verfahren zu ihrer Herstellung
DE2439453A1 (de) 3-desoxyglucose- und3,4-didesoxyglucosederivate
CH653340A5 (de) (e)-5-(2-bromvinyl)-uridine und verfahren zu ihrer herstellung.
DE2731306C3 (de) 9-Desacetyl- und 9-Desacetyl-9-epi-daunorubicin, Verfahren zu deren Herstellung und deren Verwendung
DE1543203A1 (de) Neue Furanoside und Verfahren zu ihrer Herstellung
DE1958514A1 (de) Verfahren zur Herstellung von Apovincaminsaeureamiden
DE3200809C2 (de) 4'-Desoxy-3'-epi-daunorubicin und -doxorubicin, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69309293T2 (de) 2-substituierte adenosine mit a-2 rezeptor affinität
DE2656604C3 (de) Verfahren zur Herstellung von 1 -(2-Tetrahydrofuryl)-5-fluor-uracil
DE2714883A1 (de) Nicht-glykosidische theophyllin- zucker-derivate
CH643831A5 (de) Cinnamyl-moranolin-derivate.
DE2003043C3 (de) Verfahren zur Herstellung von 2,6-Bis-(diäthanolamino)-4,8-di- piperidino-pyrimido [5,4d] pyrimidin
DE2529293A1 (de) 3',4'-anhydro-5,6-0-cyclohexylidenneamin-derivate und ihre herstellung
DE3619617A1 (de) Verfahren zur herstellung von 2-brom-(alpha)-ergokryptin
DE2618721C2 (de) Benzo(b)-bicyclo[3,3,1]nonene, Verfahren zu deren Herstellung und pharmazeutische Mittel, die diese Verbindungen enthalten
AT299239B (de) Verfahren zur Herstellung von neuen 4-(9-Adenyl)-2,3-dihydroxy-buttersäure und ihrer Salze
DE2026040A1 (de) Imidazolnbosylcyclophosphate